SCHEMBL5155488

SCHEMBL5155488

O=C(O)c1ccc(CN2C(=O)CNC23CCN(C(=O)c2cccnc2Cl)CC3)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
CYP2C19 P33261 3/20 0.41
PARP1 P09874 2/20 0.41
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CHRM2 P08172 2/20 0.38
PIK3CG P48736 2/20 0.38
CYP3A4 P08684 3/20 0.38
CYP46A1 Q9Y6A2 2/20 0.38
CYP2C8 P10632 1/20 0.38
CYP2C9 P11712 1/20 0.38
MEN1 O00255 1/20 0.37
TP53 P04637 1/20 0.37
PABPC1 P11940 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP2D6 P10635 2/20 0.36
RIPK1 Q13546 1/20 0.36
TSHR P16473 1/20 0.36
HIF1A Q16665 1/20 0.36
EPAS1 Q99814 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5174941 0.83 IP6K1 (0.38) CYP2C19CHRM2CYP3A4CYP2C9MEN1
SCHEMBL5152604 0.77 HDAC1 (0.45) LMNASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL1802003 0.77 SMN1; SMN2 (0.50) CYP2C19SMN1; SMN2CHRM2CYP3A4CYP2D6
SCHEMBL5151551 0.77 MEN1 (0.51) SMN1; SMN2MEN1KMT2ACYP2D6RIPK1
SCHEMBL5155027 0.76 L3MBTL1 (0.44) SMN1; SMN2MEN1TP53KMT2ATSHR
SCHEMBL1801385 0.74 RIPK1 (0.52) POLBCYP2C19LMNACHRM2CYP3A4
SCHEMBL1801939 0.73 OPRD1 (0.47) LMNACYP3A4CYP2C9CYP2D6TSHR
SCHEMBL1803702 0.73 CYP2C19 (0.43) POLBCYP2C19PARP1LMNASMN1; SMN2
SCHEMBL5151635 0.73 KMT2A (0.42) SMN1; SMN2MEN1TP53KMT2ATSHR
SCHEMBL24106950 0.70 OPRD1 (0.46) CYP2C19LMNACHRM2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070015784-A1 Subsitituted 1,4,8- triazaspiro [4,5]decan-2-one compounds GRUENENTHAL GMBH (DE) 2007-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015784-A1 Subsitituted 1,4,8- triazaspiro [4,5]decan-2-one compounds SI, SSTR4, SLC10A2 POLB 2915/4885CYP2C19 295/4885PARP1 340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.